(S)-1-Cyclohexyl-2,2,2-trifluoro-ethylamine, 98.0%, 250mg

Ethyl 2-Hydroxycyclopentanecarboxylate, 97.0%, 10g

(4Z)-4-(4-bromobenzylidene)-2-(methylthio)-1,3-thiazol-5(4H)-one, 95.0%, 1g

5-BROMOMETHYL-INDAN, 95.0%, 250mg

Sample beakers with screw closure without graduation, without labelling area, 200 ml, Sterile, 150 Piece(s)

(2R,3R,4R,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-[(4-chlorobenzoyloxy)methyl]-4-fluoro-4-methyloxolan-3-yl 4-chlorobenzoate, 97%, 100mg

Tert-butyl methyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)carbamate, 98%, 1g

Sudan I>93.0%(HPLC)25g

Ethyl 4-iodo-3-methylbenzoate, 98.0%, 1g

N-ISOBUTYL-4-OXO-3,4-DIHYDROQUINAZOLINE-7-CARBOXAMIDE, 95.0%, 250mg

1-Benzyl-1H-imidazole, 97.0%, 500g

2-(2,5-Dibromophenyl)ethanol, 98%, 100mg

2,5-Dimethylcyclohexanone (mixture of isomers)>95.0%(GC)25mL